Shanghai Zerun Biotechnology, Walvax Biotechnology: 202-CoV
Vaccine Type: Protein Subunit
This vaccine may also be referred to as ZR-202-CoV
Vaccine Trial & Approval Tracker
-
Phase 1
-
Phase 2
-
Phase 3
-
Approved
This vaccine has reached Phase 2 trials.
About Trial Phases
Phase 3:
0
Trials
There are no trials for this phase.
Approvals
This vaccine is not yet approved.
Registered Trials
-
NCT04990544
Phase 2
China
Total Enrollment: 1,056
Official Trial Registration:
-
NCT05490108
Phase 1/2
Mali
Total Enrollment: 60
Official Trial Registration:
-
NCT05313022
Phase 1/2
China
Total Enrollment: 84
Official Trial Registration:
-
NCT04982068
Phase 1
China
Total Enrollment: 144
Official Trial Registration:
